Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

NCT00408499 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: cetuximab
DRUG: erlotinib

Sponsor

University of California, Davis

Collaborators

[object Object]